Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 6:08 pm Sale |
2022-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 5,172 1.600% |
-17,821 (-77.50%) |
Filing History |
| 2023-02-13 6:05 pm Purchase |
2022-12-31 | 13G | Elevation Oncology, Inc. ELEV |
BIOTECHNOLOGY VALUE FUND L P | 2,312,200 9.900% |
700,502 (+43.46%) |
Filing History |
| 2023-02-13 6:02 pm Purchase |
2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BIOTECHNOLOGY VALUE FUND L P | 4,917,774 9.990% |
1,321,017 (+36.73%) |
Filing History |
| 2023-02-13 6:00 pm Purchase |
2022-12-31 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 3,780,694 7.900% |
437,500 (+13.09%) |
Filing History |
| 2023-02-13 5:57 pm Sale |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
BIOTECHNOLOGY VALUE FUND L P | 1,353,815 2.900% |
-235,680 (-14.83%) |
Filing History |
| 2023-02-13 5:55 pm Purchase |
2022-12-31 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 8,291,988 19.800% |
150,000 (+1.84%) |
Filing History |
| 2023-02-13 5:53 pm Purchase |
2022-12-31 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 7,428,379 8.900% |
366,000 (+5.18%) |
Filing History |
| 2023-02-13 5:53 pm Purchase |
2022-12-31 | 13G | Viracta Therapeutics, Inc. VIRX |
BIOTECHNOLOGY VALUE FUND L P | 3,833,785 9.980% |
102,041 (+2.73%) |
Filing History |
| 2023-02-13 5:51 pm Sale |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BIOTECHNOLOGY VALUE FUND L P | 75,280 1.900% |
-25,642 (-25.41%) |
Filing History |
| 2023-02-13 5:28 pm Purchase |
2023-02-03 | 13G | Structure Therapeutics Inc. GPCR |
BIOTECHNOLOGY VALUE FUND L P | 12,660,518 11.100% |
12,660,518 (New Position) |
Filing History |
| 2023-02-06 4:43 pm Purchase |
2023-01-25 | 13G | Jasper Therapeutics, Inc. JSPR |
BIOTECHNOLOGY VALUE FUND L P | 990,000 9.100% |
990,000 (New Position) |
Filing History |
| 2023-01-03 5:01 pm Purchase |
2022-12-22 | 13G | Zymeworks Inc. ZYME |
BIOTECHNOLOGY VALUE FUND L P | 5,870,000 9.300% |
5,870,000 (New Position) |
Filing History |
| 2022-12-23 5:08 pm Sale |
2022-12-21 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 22,993 7.400% |
-28,199 (-55.08%) |
Filing History |
| 2022-12-21 4:40 pm Purchase |
2022-12-19 | 13G | Third Harmonic Bio, Inc. THRD |
BIOTECHNOLOGY VALUE FUND L P | 4,365,933 10.800% |
864,119 (+24.68%) |
Filing History |
| 2022-12-16 4:45 pm Purchase |
2022-12-06 | 13G | NLS Pharmaceutics AG NLSP |
BIOTECHNOLOGY VALUE FUND L P | 171,479 19.990% |
171,479 (New Position) |
Filing History |
| 2022-12-05 4:45 pm Purchase |
2022-11-23 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 3,547,083 5.300% |
2,301,171 (+184.70%) |
Filing History |
| 2022-11-10 4:51 pm Unchanged |
2022-11-08 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 3,526,729 14.200% |
0 (Unchanged) |
Filing History |
| 2022-11-07 4:50 pm Purchase |
2022-10-27 | 13G | Aravive, Inc. ARAV |
BIOTECHNOLOGY VALUE FUND L P | 6,109,058 9.990% |
6,109,058 (New Position) |
Filing History |
| 2022-09-29 4:28 pm Purchase |
2022-09-19 | 13G | Allakos Inc. ALLK |
BIOTECHNOLOGY VALUE FUND L P | 5,006,921 5.900% |
5,006,921 (New Position) |
Filing History |
| 2022-09-26 4:57 pm Purchase |
2022-09-15 | 13G | Third Harmonic Bio, Inc. THRD |
BIOTECHNOLOGY VALUE FUND L P | 3,501,814 9.100% |
3,501,814 (New Position) |
Filing History |